Drug Shortage Report for TRULICITY

Last updated on 2021-10-06 History
Report ID 145857
Drug Identification Number 02448602
Brand name TRULICITY
Common or Proper name DULAGLUTIDE
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) DULAGLUTIDE
Strength(s) 1.5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 x 0.5 ml single-use prefilled pen
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-10-07
Actual start date
Estimated end date
Actual end date 2021-10-06
Shortage status Avoided shortage
Updated date 2021-10-06
Company comments Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays)
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-10-06 French Compare
v7 2021-10-06 English Compare
v6 2021-10-05 French Compare
v5 2021-10-05 English Compare
v4 2021-09-23 French Compare
v3 2021-09-23 English Compare
v2 2021-09-17 French Compare
v1 2021-09-17 English Compare

Showing 1 to 8 of 8